Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
Kaku
M
M
Second Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Ishida
K
K
Kohno
S
S
Koga
H
H
Hara
K
K
Usui
T
T
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006224:Cricetinae; D024841:Fluoroquinolones; D006801:Humans; D008168:Lung / Q000382:microbiology; D008297:Male; D008647:Mesocricetus; D008826:Microbial Sensitivity Tests; D009177:Mycoplasma pneumoniae / Q000187:drug effects*; D015242:Ofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy* / Q000382:microbiology; D015363:Quinolones / Q000494:pharmacology* / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D015242:Ofloxacin; C061363:sparfloxacin